Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Comparison of Hormonal vs Mechanical Contraception for Reduction of Trophoblastic Sequelae Following Hydatidiform Mole

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				GOG-55


2.		Phase III Randomized Trial of Hormone Therapy with TMX vs MEG vs TMX plus MEG in Patients with Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NEDH-D-83007 NCI-V85-0130

Last Modified: 7/30/2008 First Published: 4/1/2002


3.		Phase II Randomized Study of Medroxyprogesterone Versus Ethinyl Estradiol and Norgestrel For the Prevention of Endometrial Carcinogenesis in Women With a Known Hereditary Non-Polyposis Colon Cancer (HNPCC)-Associated Gene Mutation or HNPCC-Associated Cancer(s)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				25 to 50				NCI				MDA-ID-01340 TX035, NCI-P02-0218, N01-CN-05127, NCT00033358


4.		Phase II Sequential Treatment with Ethinyl Estradiol and MPA for Metastatic and/or Recurrent Breast Cancer in Postmenopausal Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				75 and under								PCCC-83239 NCI-V83-0354


5.		Phase II Evaluation of the Effect of Estrogenic Recruitment on Response to FAC Combination Chemotherapy for Advanced Stage III/IV Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 71								EORTC-10807


6.		Phase II Hormone Manipulation Therapy with Ethinyl Estradiol and MPA for Recurrent Epithelial Ovarian Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				45 and over								MDA-G-8006 NCI-V84-0022

Last Modified: 8/1/1991


7.		Phase II Study of CALF-E (CTX/ADR/CF/5-FU/Ethinyl Estradiol) Induction and Radiotherapy in Patients with Breast Cancer Stages III and IV, Clinical T3N0, and Stage II with Four or More Positive Nodes (Summary Last Modified 08/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								GUMC-7589 NCI-V89-0179

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute